Workshop to review drugs for schizophrenia


The Department of Health and Social Development will host a Drug Utilization Review (MUR) workshop of antipsychotics for patients with schizophrenia in the Virgin Islands.

Head of Medicines and Pharmaceutical Services, Ms Gracia Wheatley-Smith, said a case study was carried out at the Health Services Authority (BVIHSA) from February 1 to March 6, where 153 prescriptions were checked to examine the how drugs were prescribed.

Ms Wheatley-Smith said the study results were assessed against several internationally recognized standards, including the American Psychiatric Association’s practice guidelines for the treatment of schizophrenia and the clinical guidelines of the National Institute for Health. and Care Excellence (NICE) for psychosis, schizophrenia in adults. .

The Chief Medicines Officer explained that a Drug Utilization Review (DUR) or DUR is defined as an authorized, structured, and ongoing review of drug prescribing, dispensing, and use.

“We want to ensure that the prescription of drugs meets international standards. The workshop will be held on May 5 at 7:00 p.m. via the Zoom platform and will be used to present the results of the drug utilization review. It will also highlight any deviations from international standards and provide recommendations to address these gaps to ensure patients receive optimal care,” the chief said.

Mr. Abraham Weekes, Registered Pharmacist and Lead Technical Specialist for the OECS PPS Quality Assurance Program, and BVIHSA Psychiatrist Dr. June Samuel will facilitate the workshop.

Mr. Weekes will give a presentation on the study while Dr. Samuel will talk about the treatment of schizophrenia since the study was conducted.

Interested healthcare professionals and community members can register to attend this workshop, which has been awarded to 3 CMEs, by contacting Ms. Wheatley-Smith at 468-9850 or email [email protected] .vg.

Participation in this workshop is free and requires registration. People are invited to register early to reserve a space because the platform has a capacity of 100 people.

The World Health Organization (WHO) defines schizophrenia as a condition characterized by significant impairments in the way reality is perceived and behavioral changes related to persistent delusions, persistent hallucinations; the experience that one’s feelings, impulses, actions, or thoughts are not self-generated; and disorganized thinking.

People with schizophrenia also often experience persistent difficulties with their cognitive or thinking abilities, such as memory, attention, and problem solving.

The review was undertaken by the Organization of Eastern Caribbean States Procurement and Supply Chain Management Unit (OECS/PPS), BVI Health Services Authority and coordinated by the Bureau the head of the pharmaceutical and pharmaceutical services of the Ministry of Health and Social Development.

The Government of the Virgin Islands is committed to improving the health of the people of the Virgin Islands.


Comments are closed.